A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer.

Sun, J M; Kim, J R; Do, I G; Lee, S Y; Lee, J; Choi, Y L; Ahn, J S; Ahn, M J; Park, K.
Br J Cancer; 109(6): 1482-7, 2013 Sep 17.
Artigo em Inglês | MEDLINE | ID: mdl-23963141